Supplementary Table 1 from Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors

Autor: Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Rok vydání: 2023
DOI: 10.1158/1078-0432.22465241.v1
Popis: Distribution of disruptive and non-disruptive mutations in the different types of TP53 mutations
Databáze: OpenAIRE